The fraction of Americans 65 and older is expected to double by 2060.13 Unless significant progress is made in
the treatment of age-related diseases, this fundamental demographic shift will herald drastic economic and
social challenges. The study of aging in S. cerevisiae has revealed fundamental insights into the most common
causes of mortality including cancer, cardiovascular disease, neurodegeneration, and diabetes.14–16
Using a microfluidic device, we can monitor the yeast aging process at single-cell resolution via time-lapse
microscopy. This device also allows us to study environmental perturbations of aged cells. Microfluidic trapping
is a rare validated method for collection of longitudinal, dynamic, in situ aging data at single-cell
resolution. I will exploit this device to perform whole-lifespan monitoring of yeast cell towards the following
specific aims:
Aim 1: Determine mechanism of iron starvation response in age-related mitochondrial dysfunction
Mitochondrial dysfunction has been implicated as a driver of multiple age-related diseases,17 and changes in
mitochondrial phenotype have been mechanistically tied to yeast RLS.18 Previous research has linked an early
life loss of vacuolar acidity to later mitochondrial dysfunction.19 Preliminary data indicates that an iron
starvation response mediates this process. I will affirm the links between vacuolar acidity, iron regulation, and
mitochondrial dysfunction and determine the causal mechanism of these connections.
Aim 2: Determine mechanism of age-related loss of mother-daughter lifespan asymmetry
Asymmetric cell division is a hallmark of metazoan life, with important implications in both development and
age-related pathology.20,21 Contrary to popular assumption in the yeast aging field, I have observed a
progressive age-dependent decline in mother-daughter lifespan asymmetry that begins early in life. I
hypothesize that this decline is due to a progressive decline in the septin-mediated cortical and membrane
diffusion barrier. I will investigate the kinetics and the mechanism of this loss of asymmetry.
Aim 3: Define role of age-related loss of fidelity in MSN2 glucose-sensing signal transduction
Aging is characterized by a reduced ability to maintain homeostasis in response to environmental change.22,23
Our microfluidic device makes it possible to perturb and observe aged cells. I have found that MSN2 signaling
differs between young and old cells in the same environment. Moreover, I have found that cells exposed to
temporally varying environments as they age have shorter lifespans. I hypothesize that the MSN2 loses
glucose-signaling transmission fidelity due to its role in reporting of increased oxidative stress with age. I will
characterize this loss of information transfer and determine whether it is responsible for an age-related loss of
resilience.
Public Health Relevance Statement
PROJECT NARRATIVE
Lay statement:
The aging process drives development of neurodegeneration, cancer, cardiovascular disease and many other
diseases. We will learn more about the molecular mechanisms of aging by trapping and monitoring single
yeast cells as they age. Specifically, we will learn about changes in mitochondrial health and coordination of
protein expression during aging.
No Sub Projects information available for 5F30AG052225-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5F30AG052225-04
Patents
No Patents information available for 5F30AG052225-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5F30AG052225-04
Clinical Studies
No Clinical Studies information available for 5F30AG052225-04
News and More
Related News Releases
No news release information available for 5F30AG052225-04
History
No Historical information available for 5F30AG052225-04
Similar Projects
No Similar Projects information available for 5F30AG052225-04